ICONplc.com/RWI Real World Evidence Technology Platform Optimise Real World Data Use to Drive Effective Outcomes Real world evidence (RWE) continues to drive healthcare and research discussions and decisions. ICON works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety and cost-effectiveness evidence that regulators, payers and providers demand. ICON’s holistic solution provides many distinct advantages including integrated domain expertise from across multiple disciplines covering epidemiology, data science, HEOR, study feasibility, market access and regulatory affairs. This expertise, combined with access to a diverse set of global RWD sources and a proven advanced analytics platform provider, Saama Technologies, creates a unique combination to more completely serve the expanding needs of biopharma’s Medical Affairs and RWE Centers of Excellence functions. ICON’s Strategic Approach to Actionable RWE Generation Our Commercialisation and Outcomes experts will collaborate with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency, and targeted plans that can enhance your value story and provide compelling evidence for stakeholder engagement. We call this approach Real World Intelligence ™ . From interactive evidence planning workshops and strategy creation to implementation of innovative technology and RWD solutions, the ICON RWE team will ensure that you are on the clear path to commercial success, equipped with the right RWD assets to generate impactful evidence. RWE Planning Workshops and Strategy Creation Our interactive workshop approach brings together subject matter and functional experts to create a roadmap that aligns with your strategic objectives. You get a step-by-step plan to identify and execute a comprehensive RWE strategy customised for your specific asset. Identify Review product and portfolio objectives Assess Conduct a situational assessment Determine Recognise opportunities and challenges Define timing and resources for studies Plan Implement RWE generation and RWD acquisition plan Execute
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
ICONplc.com/RWI
Real World Evidence Technology PlatformOptimise Real World Data Use to Drive Effective Outcomes
Real world evidence (RWE) continues to drive healthcare and research discussions and decisions. ICON works with biopharmaceutical and medical device companies to identify, generate, and communicate the clinical, safety and cost-effectiveness evidence that regulators, payers and providers demand.
ICON’s holistic solution provides many distinct advantages including integrated domain expertise from across multiple disciplines covering epidemiology, data science, HEOR, study feasibility, market access and regulatory affairs. This expertise, combined with access to a diverse set of global RWD sources and a proven advanced analytics platform provider, Saama Technologies, creates a unique combination to more completely serve the expanding needs of biopharma’s Medical Affairs and RWE Centers of Excellence functions.
ICON’s Strategic Approach to Actionable RWE GenerationOur Commercialisation and Outcomes experts will collaborate with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency, and targeted plans that can enhance your value story and provide compelling evidence for stakeholder engagement. We call this approach Real World Intelligence™.
From interactive evidence planning workshops and strategy creation to implementation of innovative technology and RWD solutions, the ICON RWE team will ensure that you are on the clear path to commercial success, equipped with the right RWD assets to generate impactful evidence.
RWE Planning Workshops and Strategy CreationOur interactive workshop approach brings together subject matter and functional experts to create a roadmap that aligns with your strategic objectives. You get a step-by-step plan to identify and execute a comprehensive RWE strategy customised for your specific asset.
RWE Technology SolutionsThe evidence generated from collecting, standardising and analysing RWD from primary and secondary sources can be used across an array of late phase research applications. With a full understanding of the novel RWD sources and innovative technologies to gather, process and analyse them, a more robust approach exists for creating RWE results.
RWE Technology PlatformICON provides a configurable technology platform, leveraging Saama’s Life Science Analytics Cloud, that is a fit-for-purpose solution to support and enhance your observational research needs, to gather disparate RWD assets into a common data model, provide analytics to support multiple audiences across the product lifecycle, and establish a central repository and analytic platform for all of your RWD assets. Key capabilities provided by the platform include:
Powered by
Life Science Analytics Cloud
Data Parsing & Integration
Data Quality
Common Data Model
Machine Learning
Analysis
Governance, Compliance & Monitoring
Patient Inputs
ProviderInputs
Trial Management
Inputs
OtherInputs
Accelerate Patient Population Identi�cation/Recruitment
Better Business & Patient Outcomes
Shorten Trial Design, Site/PI Selection Time & Costs
Patient Data Standardisation & Analytics
Predictive Operational KPIs
Risk Identi�cation
Modern Patient Registries
Value-based Reimbursements
KOL Engagement
Patient Journey
Treatment Pathways
Payer Insights
Market Analysis
AI/ML based Literature Review
Insights
Protocol Design (I/E Recommender)
Predictive Protocol & Trial Feasibility
Predictive Site, PI, Patient Identi�cation and Enrolment Forecasting
Study Start-up Automation
Planning
Start Up
Conduct
RWE
Patient Matching
Trial Feasibility RWD
Study Management
Sample Ecosystem
Let our industry experts work for youContact us today at ICONplc.com/contact
For access to our webinars and whitepapers, visit ICONplc.com/RWI